Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1093/ckj/sfx128 http://scihub22266oqcxt.onion/10.1093/ckj/sfx128 C6007417!6007417!29988247     free     free     free Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 265.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Clin+Kidney+J 2018 ; 11 (3): 422-8 Nephropedia Template TP {{tp|p=29988247|t=2018. The utility of phospholipase A2 receptor autoantibody in membranous nephropathy after kidney transplantation |pdf=|usr=}}{{29988247}} gab.com Text The utility of phospholipase A2 receptor autoantibody in membranous nephropathy after kidney transplantation JO: Clin Kidney J http://www.kidney.de/pget.php?&tw=1&pmid=29988247 #FOAvip Membranous nephropathy (MN) is estimated to cause end-stage renal disease in ??5% of patients, in whom renal transplantation is the therapy of choice. Among patients receiving a transplant for MN, the disease will recur in the graft in 30?50%; among these, graft loss will occur in 50% within 10 years. Several studies have suggested that phospholipase A2 receptor autoantibody (aPLA2R) levels before transplantation might be useful in predicting recurrence, and their titration after transplantation is clinically relevant to assess the risk of recurrence and progression, to guide treatment indications and to monitor treatment response. In this review we describe the evolving role of aPLA2R as a biomarker in primary MN and its current usefulness in predicting recurrence of this autoimmune podocytopathy after renal transplantation. Twit Text FOAVip The utility of phospholipase A2 receptor autoantibody in membranous nephropathy after kidney transplantation ????Clin Kidney J http://www.kidney.de/pget.php?&tw=1&pmid=29988247 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=29988247 #FOAvip English Wikipedia <ref>{{Cite pmid|29988247}}</ref> The utility of phospholipase A2 receptor autoantibody in membranous nephropathy after kidney transplantation #MMPMID29988247 Xipell M; Rodas LM; Villarreal J; Molina A; Reinoso-Moreno J; Blasco M; Poch E; Diekmann F; Campistol JM; Quintana LF Clin Kidney J 2018[Jun]; 11 (3): 422-8 PMID29988247show ga Membranous nephropathy (MN) is estimated to cause end-stage renal disease in ??5% of patients, in whom renal transplantation is the therapy of choice. Among patients receiving a transplant for MN, the disease will recur in the graft in 30?50%; among these, graft loss will occur in 50% within 10 years. Several studies have suggested that phospholipase A2 receptor autoantibody (aPLA2R) levels before transplantation might be useful in predicting recurrence, and their titration after transplantation is clinically relevant to assess the risk of recurrence and progression, to guide treatment indications and to monitor treatment response. In this review we describe the evolving role of aPLA2R as a biomarker in primary MN and its current usefulness in predicting recurrence of this autoimmune podocytopathy after renal transplantation. äThe utility of phospholipase A2 receptor autoantibody in membranous ne(epmc).pdf DeepDyve Pubget Overpricing